0.15Open0.15Pre Close0 Volume1 Open Interest25.00Strike Price0.00Turnover1692.02%IV181.95%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.0775Delta0.0272Gamma59.47Leverage Ratio-0.8061Theta0.0000Rho4.61Eff Leverage0.0005Vega
Perspective Therapeutics Stock Discussion
Larger Image: tradingview.com...
$Perspective Therapeutics (CATX.US)$
$Perspective Therapeutics (CATX.US)$
1:10
$Virgin Galactic (SPCE.US)$ 1:20
$Star Equity (STRR.US)$ 1:5
$Workhorse (WKHS.US)$ 1:20
FDA Selects Perspective Therapeutics To Participate In The CDRP Program To Expedite Chemistry, Manufacturing, and Controls Development Readiness For VMT-α-NET in Neuroendocrine Tumors
No comment yet